BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 13, 2006
View Archived Issues
Roche and Amira sign research collaboration and licensing option agreements
Read More
Cellegesic to be reviewed by FDA Advisory Committee in April
Read More
Preclinical findings show Miraxion has neuroprotective effects in Parkinson's
Read More
Second phase I trial begins for third-generation taxane TPI-287
Read More
Series B financing to support pipeline development at Xytis
Read More
Hana demonstrates bioequivalence of Zensana ondansetron oral spray
Read More
TAP terminates sublicensing agreement with Santarus
Read More
IND submission for BEMA LA for moderate to severe pain
Read More
Enrollment open in phase IIb kidney transplant study of ISA-247
Read More
Phase I study for PV-903 for treatment of recurrent miscarriages
Read More
Ibuprofen may delay or prevent PD
Read More
MUC1 immunoassay may detect pancreatic cancer
Read More
Neurocrine updates FDA review of indiplon NDAs
Read More
Hemopure to be submitted for European approval in mid-2006
Read More
EntreMed completes Miikana acquisition
Read More
PR Pharmaceuticals and OSI collaborate on sustained-release Macugen
Read More
GlobeImmune closes Series B financing
Read More
European orphan drug designation for Amplimexon in ovarian cancer
Read More
MRE-0094 enters phase II for chronic neuropathic diabetic foot ulcers
Read More
Phase III program commences for Vanquix for acute, repetitive epileptic seizures
Read More
New analogue of celecoxib mimics antitumor activity in MM without COX-2 inhibition
Read More
Novel antiinfective agents disclosed in recent Johnson & Johnson patent
Read More
Vitragan MAA accepted for review
Read More
Recent patents report new therapeutic agents for diabetes and other endocrine-related disorders
Read More
Fast track designation for FavId in B-cell follicular NHL
Read More
LSN-2120310's activity against a wide range of menopausal symptoms
Read More